Rheumatoid Arthritis Causally Linked to Prostate Cancer
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Jan. 29, 2025 -- Genetically predicted rheumatoid arthritis (RA) is causally associated with prostate cancer (PCa), according to a study published online Jan. 10 in Medicine.
Shihua Ye, from Mindong Hospital Affiliated to Fujian Medical University in China, and colleagues examined the causal association between three common autoimmune diseases: RA, systemic lupus erythematosus (SLE), and ankylosing spondylitis (AS) and the risk for PCa. Genome-wide association studies summary statistics were used to conduct forward and reverse Mendelian randomization (MR). Risk factors, including smoking and obesity, were also incorporated in the multivariable MR analysis.
The researchers found that genetically predicted RA was associated with an increased risk for PCa in a univariable MR analysis (odds ratio, 1.036; 95 percent confidence interval, 1.022 to 1.049). No significant association was seen for SLE or AS with PCa. The positive association between RA and PCa was confirmed in a multivariable MR analysis adjusted for smoking and obesity. No significant inverse causal associations were seen between PCa and the three autoimmune diseases in a reverse MR analysis.
"The positive association between genetically predicted RA and PCa risk found in our study highlights the importance of monitoring PCa risk in patients with RA. Clinicians should be aware of this potential comorbidity and consider including PCa screening in routine checkups for RA patients," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Psoriatic Arthritis Tied to Delays in Diagnosis Compared With Rheumatoid Arthritis
WEDNESDAY, April 30, 2025 -- Patients with psoriatic arthritis (PsA) have delays in diagnosis compared with those with rheumatoid arthritis (RA), according to a study published...
MicroRNA-Based Germline Signature Predicts RT-Induced Genitourinary Toxicity in Prostate Cancer
FRIDAY, April 18, 2025 -- A biomarker consisting primarily of microRNA-based germline biomarkers (mirSNPs), PROSTOX, is valid for predicting radiotherapy (RT)-induced...
Prostate Cancer Screening Program Beneficial in Top Decile of Polygenic Risk Score
MONDAY, April 14, 2025 -- A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score identifies clinically...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.